Why "Identity: Conforms" Rests on a Peptide Map
A certificate of analysis for a research-grade peptide carries a line that reads something like Identity: Conforms. Two words, doing an enormous amount of work. All material discussed here is supplied for research use only, and the question those two words answer is narrow but fundamental: is the molecule in the vial actually the amino acid sequence printed on the label? That's a different question from how pure the material is, and different again from how much peptide the vial contains. The method standing behind that line is usually peptide mapping.
It's also the part of the report most people skim. It deserves better. What follows is what a peptide map is, how the workflow runs, what the numbers mean, where the method quietly misleads, and why the regulatory framework asks for it at all.
Why Fragments Tell You More Than the Intact Molecule
The short answer: one number can hide a lot. A pattern of many numbers can't.
Measuring the mass of an intact peptide is fast and genuinely useful — but it returns a total, and totals conceal compensating differences. Swap one amino acid for a heavier one and another for a lighter one, and the sum lands exactly where it was supposed to. The molecule is wrong; the number is right. Intact mass is a necessary check, not a sufficient one.
Peptide mapping works the way a fingerprint database works. An enzyme cleaves the molecule into smaller pieces at known positions, and the mass of each piece gets measured. Software then runs the same digestion computationally on the reference sequence, calculates the theoretical fragment masses, and compares the measured peak list against the predicted one statistically. The map isn't a picture of the molecule. It's a list of fragment masses whose pattern is near-unique to one sequence.
That distinction matters when you're reading orthogonal tests. Amino acid analysis tells you which residues are present and in what proportion — composition, not order. Hydrolyze a sequence and its scrambled twin and the results look identical. Mapping gets at order, because cutting at defined positions makes position itself observable.
Before any of this, sequence confirmation meant Edman degradation, which chewed through roughly an hour per amino acid residue and could not characterize post-translational modifications at all. Mapping is faster and sees more. That's the whole reason the field moved.
The Four-Stage Workflow
Every peptide map, whatever the lab, runs the same four stages. Knowing them makes the report legible.
Stage one — denature, reduce, alkylate
The enzyme has to physically reach its cut sites, so the molecule is first unfolded using chaotropic salts. Disulfide bonds are then broken with a reducing agent such as TCEP, and the freed cysteines capped by alkylation so the bridges can't re-form mid-experiment. This preparation is what makes complete coverage achievable — and, as we'll see, it's where some artifacts are born.
Stage two — enzymatic digestion
Trypsin is the default because it cleaves predictably on the carboxyl side of lysine and arginine. Predictable means computable: the expected fragment list exists before anything runs. Chymotrypsin and Glu-C cut at different residues and get pulled in when trypsin leaves a region uncovered. Endoproteinase Lys-C shows up in platform methods because it yields a simpler peptide pattern than tryptic digestion — an advantage when the goal is a routine identity check rather than exhaustive characterization. Digestion commonly runs overnight.
Stage three — chromatographic separation
The fragment mixture goes onto a reversed-phase column, which separates pieces by hydrophobicity. Retention time isn't just a convenience here — it distinguishes isomers that mass measurement alone can't tell apart. One published platform method runs a peptide-grade C18 column at 80 °C with a total separation time of 26.4 minutes: a routine analytical run, not a multi-day undertaking.
Stage four — detection
Ultraviolet detection produces a pattern of peaks. Mass spectrometry produces an identity for each peak. High-resolution instruments in the Orbitrap class handle full characterization work, while a single-quadrupole detector is sufficient when the method targets a small number of known marker peptides.